Jones Financial Companies’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-98
Closed -$4K 808
2022
Q4
$4K Buy
+98
New +$3.87K ﹤0.01% 572
2022
Q3
Sell
-35
Closed -$3K 760
2022
Q2
$3K Sell
35
-7
-17% -$512 ﹤0.01% 586
2022
Q1
$3K Buy
+42
New +$3.55K ﹤0.01% 637
2021
Q3
Sell
-12
Closed -$1K 668
2021
Q2
$1K Hold
12
﹤0.01% 624
2021
Q1
$1K Sell
12
-192
-94% -$14.5K ﹤0.01% 776
2020
Q4
$14K Buy
+204
New +$12.7K ﹤0.01% 404

Other funds holding SYNH

Jones Financial Companies's SYNH Position: Q1 2023 in Review

Jones Financial Companies sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 98 shares — an estimated $4K sold.

Jones Financial Companies first reported a position in SYNH in Q4 2020 and held it in 6 quarters. The position peaked at $14K in Q4 2020. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Jones Financial Companies reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jones Financial Companies sold 98 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $4K.
  • Jones Financial Companies first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
  • Jones Financial Companies's Syneos Health, Inc. Class A Common Stock position peaked at $14K in Q4 2020.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Jones Financial Companies's 13F filing for Q1 2023, filed 11 May 2023.